Today, more and more complementary therapies are being integrated into care plans for patients with prostate cancer. Read the article here.
Data from the survival outcomes of patients support the use of active surveillance in low risk and intermediate risk cases of Gleason 6 but not Gleason 7 prostate cancer. Multiparametric magnetic resonance imaging and novel biomarkers might be vital in detecting favorable Gleason 7 disease. Read the article here.
A recent large U.S. study designed to gauge the health benefits of vitamin D and fish oil supplements concludes that the omega-3 oil can dramatically reduce the odds of a heart attack while vitamin D’s benefits seem to come from lowering the risk of death from cancer. Neither vitamin D nor fish oil lowered the odds of stroke or of getting cancer in the first place in the trial. Read the article here.